Tramadol-induced seizurogenic effect: A possible role of opioid-dependent γ-aminobutyric acid inhibitory pathway

Ashish K. Rehni, Inderbir Singh, Manoj Kumar

Research output: Contribution to journalArticlepeer-review

57 Scopus citations

Abstract

The present study has been designed to pharmacologically investigate the role of opioid and γ-aminobutyric acid receptors on the seizurogenic effect of tramadol. A single injection of pentylenetetrazole (80 mg/kg) was used to elicit seizure activity in mice. Seizures were assessed in terms of the time latency of the onset of Straub's tail phenomenon, onset of jerky movements of whole body, convulsions and death. Tramadol administration (50 mg/kg) caused a marked increase in seizurogenic activity of pentylenetetrazole as measured in terms of a significant decrease in the time latency of the onset of Straub's tail phenomenon, jerky movements of whole body, convulsions and death. Moreover, prior administration of naloxone (2 mg/kg) and gabapentin (25 mg/kg), respectively, attenuated the seizurogenic activity that tramadol exerted on pentylenetetrazole-treated mice. Furthermore, prior administration of naloxone (2 mg/kg) and gabapentin (25 mg/kg), respectively, also attenuated the seizurogenic activity exerted by tramadol per se. Therefore, it is suggested that tramadol exerts a seizurogenic effect on mice possibly via an opioid-dependent γ-aminobutyric acid inhibitory pathway.

Original languageEnglish (US)
Pages (from-to)262-266
Number of pages5
JournalBasic and Clinical Pharmacology and Toxicology
Volume103
Issue number3
DOIs
StatePublished - Sep 2008
Externally publishedYes

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology

Fingerprint

Dive into the research topics of 'Tramadol-induced seizurogenic effect: A possible role of opioid-dependent γ-aminobutyric acid inhibitory pathway'. Together they form a unique fingerprint.

Cite this